James Ede-Golightly - Director at Silence Therapeutics plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SLN on Nasdaq, SLNCF on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Ede-Golightly since 02 Feb 2025

Holdings reported by James Ede-Golightly for Silence Therapeutics plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Share Option (Right to Buy) 90,000 02 Jan 2026 Direct Ordinary Shares
Ordinary Shares 15,000 14 Dec 2025 Direct

Transactions reported by James Ede-Golightly for Silence Therapeutics plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.